Stay updated on Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page
- Check3 days agoChange DetectedThe page’s Revision tag was updated from v3.6.0 to v3.6.2, signaling a backend software release. This update underpins the page without changing the displayed study information.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and the record shows a new revision version, v3.6.0, reflecting the updated history entry.SummaryDifference0.5%

- Check25 days agoChange DetectedThe history for the record now shows Revision: v3.5.5, replacing the previous v3.5.4, indicating a software update to the page rendering.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry (Revision: v3.5.4) was added to the Record History, updating the revision timeline and replacing the previous revision (v3.5.3).SummaryDifference0.1%

- Check60 days agoChange DetectedThe page's revision label was updated from v3.5.2 to v3.5.3, indicating a new release entry for the record history. This change reflects a minor update to the page's metadata rather than a modification to the trial details.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded revision v3.5.2 to the record history and removed revision v3.5.0. This reflects version control updates and does not alter study content or page functionality.SummaryDifference0.1%

Stay in the know with updates to Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page.